ICMR moves for developing Indigenous COVID-19 Vaccine

The apex Medical Institute partners with Bharat Biotech International Limited (BBIL) for this

New Delhi: India might have its own vaccine for COVID 19. Indian Council of Medical Research (ICMR), country’s apex research institute, is in earnest and has moved forward in its quest.

Indian Council of Medical Research (ICMR) and Bharat Biotech International Limited (BBIL) have partnered to develop a fully indigenous vaccine for COVID-19 using the virus strain isolated at ICMR’s National Institute of Virology (NIV), Pune.

The strain has been successfully transferred from NIV to Bharat Biotech International Ltd. (BBIL). Work on vaccine development has been initiated between the two partners. ICMR-NIV will provide continuous support to BBIL for vaccine development. ICMR and BBIL will seek fast-track approvals to expedite vaccine development, subsequent animal studies and clinical evaluation of the candidate vaccine.

LEAVE A REPLY

Please enter your comment!
Please enter your name here